The frequency of clinical features and laboratory findings among men with adenovirus urethritis
| All men (n=102) No. (%, 95% CI) | Heterosexual men (n=61) No. (%, 95% CI) | MSM (n=41) No. (%, 95% CI) | p Value | |
|---|---|---|---|---|
| Symptoms | ||||
| Urethral discharge | 46 (45, 36 to 55) | 27 (44, 32 to 57) | 19 (46, 32 to 62) | 0.84 |
| Urethral discomfort | 49 (48, 38 to 58) | 26 (43, 31 to 55) | 23 (56, 41 to 71) | 0.18 |
| Dysuria | 85 (83, 75 to 90) | 50 (82, 70 to 90) | 35 (85, 72 to 94) | 0.65 |
| Severe dysuria | 14 (14, 8 to 21) | 7 (11, 5 to 21) | 7 (17, 8 to 31) | 0.42 |
| Signs | ||||
| Urethral discharge | 60 (59, 49 to 68) | 32 (51, 40 to 65) | 28 (68, 53 to 81) | 0.11 |
| Meatitis | 85 (83, 75 to 90) | 52 (85, 75 to 93) | 33 (80, 66 to 91) | 0.53 |
| Conjunctivitis | 39 (38, 29 to 48) | 25 (41, 29 to 54) | 14 (34, 21 to 50) | 0.47 |
| Laboratory findings | ||||
| Urethral microscopy | ||||
| Performed | 78 | 46 | 32 | |
| <5 PMNLs/HPF | 49 (63, 52 to 73) | 29 (63, 48 to 76) | 20 (62, 45 to 78) | 0.96 |
| ≥5 PMNLs/HPF | 29 (37, 27 to 48) | 17 (37, 24 to 52) | 12 (37, 21 to 55) | |
| Urethral gonorrhoea | ||||
| Performed | 94 | 54 | 40 | |
| Positive | 4 (4, 1 to 10) | 2 (4, 0.6 to 12) | 2 (5, 0.8 to 16) | |
| Urethral chlamydia | ||||
| Performed | 100 | 59 | 41 | |
| Positive | 2 (2, 0.3 to 6) | 1 (20.08 to 8.7) | 1 (2, 0.1 to 11) | |
| Urethral Mycoplasma genitalium | ||||
| Performed | 93 | 57 | 36 | |
| Positive | 1 (1, 0.05 to 5) | 0 | 1 (30.1 to 13) | |
| Urethral herpes simplex virus | ||||
| Performed | 93 | 57 | 36 | |
| Positive | 0 | 0 | 0 | |
| Conjunctival adenovirus | ||||
| Performed | 27 | 18 | 9 | |
| Positive | 23 (85, 68 to 95) | 16 (89, 68 to 98) | 7 (78, 44 to 96) | 0.44 |
HPF, high power field; MSM, men who have sex with men; PMNLs, polymorphonuclear leucocytes.